Combination therapy of immuno checkpoint inhibitors and radiosensitization treatment for metastatic melanoma
Not Applicable
- Conditions
- metastatic melanoma
- Registration Number
- JPRN-UMIN000026925
- Lead Sponsor
- Kochi University, Kochi Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) Unable to secure infusion route of drugs by using ultrasound or CT 2) Determined to have high risk for bleeding by principalinvestigator or sub-investigators 3) Determined to have high risk for infection by principalinvestigator or sub-investigators 4) Determined to be inappropriate for this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method